Although the scientific relevance of the aforementioned cardiovascular hazard factor alterations by tirzepatide might be assessed while in the prepared cardiovascular consequence examine SURPASS-CVOT ( "type":"scientific-trial","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Evaluat